35986841_10216840653711318_1105697261150535680_n
Normal view MARC view ISBD view

Enhancement of Eplerenone Dissolution Rate via Sonoprecipitation: Formulation, Evaluation, Analysis and Stability Testing // GP // Dr. Ghada Ehab Yassin // T.A. Radwa El-Masry (2018 - 2019)

By: Sally Saied Ahmed Elnaggar 151175.
Contributor(s): Fatma Mahmoud Saleh 150915 | Mayar Ayman Sabry 151827 | Mona Abdalla Omran 150921.
Material type: TextTextPublisher: Giza: MSA, 2019Description: 62 P.Subject(s): Eplerenone | SonoprecipitationOnline resources: FULL TEXT PRESS HERE Summary: Eplerenone is a selective mineralocorticoid receptor antagonist. It is used as an oral antihypertensive drug, it has very low solubility in water as according to (BCS) it belongs to Class II. This study aims to improve the solubility of poorly water-soluble eplerenone by using sonoprecipitation technique to increase the dissolution rate. Improving solubility of eplerenone is done by making eplerenone sonocrystal formulation to form a uniform and spherical shape of microcrystals using probe sonicator, followed by evaluation of the prepared sonocrystals by particle size measurement using zetasizer, Fourier transform infrared (FTIR) to determine the interaction between stabilizers (Poloxamer 188 and polyethylene glycol 6000) and drug sonocrystals, differential scanning calorimetry (DSC) to observe the changes occurred in eplerenone during spherical formulation process while X-ray diffraction (XRD) to obtain diffraction patterns for eplerenone, physical mixture, and formulations. The determination of drug content for the prepared soncrocrystal formulations was also performed. In addition, the drug release of the prepared formulae was studied and compared to pure eplerenone by in vitro dissolution. Results show that particle size range from 132nm to 455nm, FTIR and DSC shows that there’s no interaction between stabilizers and drug sonocrystals while XRD indicates the change of the drug into amorphous leading to increase the solubility, the dissolution rate was improved for all the formulations when compared with pure eplerenone. Therefore, it is concluded that the sonoprecipitation technique could be a useful technique to improve the solubility of eplerenone with a reduction in particle size, and enhanced dissolution properties.
List(s) this item appears in: Pharmacy D. G. P 2018 / 2019
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode
Distinguished Graduation Projects Distinguished Graduation Projects Centeral Library
Soft Copy located on library Cataloge
GP32PH2019 - Ceutics (Browse shelf) Available 82026

Pharmacy - Pharmaceutics

Eplerenone is a selective mineralocorticoid receptor antagonist. It is used as an oral
antihypertensive drug, it has very low solubility in water as according to (BCS) it belongs to
Class II. This study aims to improve the solubility of poorly water-soluble eplerenone by using
sonoprecipitation technique to increase the dissolution rate. Improving solubility of eplerenone
is done by making eplerenone sonocrystal formulation to form a uniform and spherical shape of
microcrystals using probe sonicator, followed by evaluation of the prepared sonocrystals by
particle size measurement using zetasizer, Fourier transform infrared (FTIR) to determine the
interaction between stabilizers (Poloxamer 188 and polyethylene glycol 6000) and drug
sonocrystals, differential scanning calorimetry (DSC) to observe the changes occurred in
eplerenone during spherical formulation process while X-ray diffraction (XRD) to obtain
diffraction patterns for eplerenone, physical mixture, and formulations. The determination of
drug content for the prepared soncrocrystal formulations was also performed. In addition, the
drug release of the prepared formulae was studied and compared to pure eplerenone by in vitro
dissolution. Results show that particle size range from 132nm to 455nm, FTIR and DSC shows
that there’s no interaction between stabilizers and drug sonocrystals while XRD indicates the
change of the drug into amorphous leading to increase the solubility, the dissolution rate was
improved for all the formulations when compared with pure eplerenone. Therefore, it is
concluded that the sonoprecipitation technique could be a useful technique to improve the
solubility of eplerenone with a reduction in particle size, and enhanced dissolution properties.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer